Matthew Jennings
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthew Jennings has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Cody Crewson
1 shared publicationDavid J. Ottaway
1 shared publication- Derek R. Lane1 shared publication
- Eva Bezak
Allied Health and Human Performance University of South Australia Adelaide South Australia Australia
1 shared publication - Fada Guan
Department of Radiation Physics MD Anderson Cancer Center Houston Texas USA
1 shared publication - Jacob McAloney
Riverina Cancer Care Centre, Wagga Wagga, Australia
1 shared publication
Latest Publications
- Open Access
- 16 October 2022
- Published by The Open Journal in Journal of Open Source Software
- Vol. 7 (78) , 4555
PyMedPhys: A community effort to develop an open, Python-based standard library for medical physics applications
- 16 October 2022
- Published by The Open Journal in Journal of Open Source Software
- Vol. 7 (78) , 4555
Open AccessPyMedPhys: A community effort to develop an open, Python-based standard library for medical physics applications
- 1 September 2017
- Published by Elsevier in Radiation Measurements
- Vol. 104, 22-31
Evaluation of the signal quality of an inexpensive CMOS camera towards imaging a high-resolution plastic scintillation detector array
- 1 September 2017
- Published by Elsevier in Radiation Measurements
- Vol. 104, 22-31
Evaluation of the signal quality of an inexpensive CMOS camera towards imaging a high-resolution plastic scintillation detector array
- Open Access
- 19 February 2015
- Published by Wiley in Computational and Mathematical Methods in Medicine
- Vol. 2015, 1-11
PET-Specific Parameters and Radiotracers in Theoretical Tumour Modelling
The innovation of computational techniques serves as an important step toward optimized, patient-specific management of cancer. In particular,in silicosimulation of tumour growth and treatment response may eventually yield accurate information on disease progression, enhance the quality of cancer treatment, and explain why certain therapies are effective where others are not.In silicomodelling is demonstrated to considerably benefit from information obtainable with PET and PET/CT. In particular, models have successfully integrated tumour glucose metabolism, cell proliferation, and cell oxygenation from multiple tracers in order to simulate tumour behaviour. With the development of novel radiotracers to image additional tumour phenomena, such as pH and gene expression, the value of PET and PET/CT data for use in tumour models will continue to grow. In this work, the use of PET and PET/CT information inin silicotumour models is reviewed. The various parameters that can be obtained using PET and PET/CT are detailed, as well as the radiotracers that may be used for this purpose, their utility, and limitations. The biophysical measures used to quantify PET and PET/CT data are also described. Finally, a list ofin silicomodels that incorporate PET and/or PET/CT data is provided and reviewed.
- 19 February 2015
- Published by Wiley in Computational and Mathematical Methods in Medicine
- Vol. 2015, 1-11
Open AccessPET-Specific Parameters and Radiotracers in Theoretical Tumour Modelling
The innovation of computational techniques serves as an important step toward optimized, patient-specific management of cancer. In particular,in silicosimulation of tumour growth and treatment response may eventually yield accurate information on disease progression, enhance the quality of cancer treatment, and explain why certain therapies are effective where others are not.In silicomodelling is demonstrated to considerably benefit from information obtainable with PET and PET/CT. In particular, models have successfully integrated tumour glucose metabolism, cell proliferation, and cell oxygenation from multiple tracers in order to simulate tumour behaviour. With the development of novel radiotracers to image additional tumour phenomena, such as pH and gene expression, the value of PET and PET/CT data for use in tumour models will continue to grow. In this work, the use of PET and PET/CT information inin silicotumour models is reviewed. The various parameters that can be obtained using PET and PET/CT are detailed, as well as the radiotracers that may be used for this purpose, their utility, and limitations. The biophysical measures used to quantify PET and PET/CT data are also described. Finally, a list ofin silicomodels that incorporate PET and/or PET/CT data is provided and reviewed.